{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:55:44Z","timestamp":1757310944106},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:00Z","timestamp":1432684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/ejhg.2015.113","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T15:02:00Z","timestamp":1432738920000},"page":"387-391","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome"],"prefix":"10.1038","volume":"24","author":[{"given":"Xue Jun","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kaito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ninchoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Morisada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norishige","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Ohtsubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Matsunoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Kamiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieko","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Taniguchi-Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,27]]},"reference":[{"key":"BFejhg2015113_CR1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1681\/ASN.V991736","volume":"9","author":"CE Kashtan","year":"1998","unstructured":"Kashtan CE : Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol 1998; 9: 1736\u20131750.","journal-title":"J Am Soc Nephrol"},{"key":"BFejhg2015113_CR2","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMra022296","volume":"348","author":"BG Hudson","year":"2003","unstructured":"Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG : Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003; 348: 2543\u20132556.","journal-title":"N Engl J Med"},{"key":"BFejhg2015113_CR3","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2009070784","volume":"21","author":"MR Bekheirnia","year":"2010","unstructured":"Bekheirnia MR, Reed B, Gregory MC et al: Genotype-phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol 2010; 21: 876\u2013883.","journal-title":"J Am Soc Nephrol"},{"key":"BFejhg2015113_CR4","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/ndt\/17.7.1218","volume":"17","author":"O Gross","year":"2002","unstructured":"Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M : Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant 2002; 17: 1218\u20131227.","journal-title":"Nephrol Dial Transplant"},{"key":"BFejhg2015113_CR5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais JP, Knebelmann B, Giatras I et al: X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol 2000; 11: 649\u2013657.","journal-title":"J Am Soc Nephrol"},{"key":"BFejhg2015113_CR6","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/ki.2013.479","volume":"85","author":"Y Hashimura","year":"2014","unstructured":"Hashimura Y, Nozu K, Kaito H et al: Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV alpha5 chain. Kidney Int 2014; 85: 1208\u20131213.","journal-title":"Kidney Int"},{"key":"BFejhg2015113_CR7","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/ndt\/gfn005","volume":"23","author":"RP Krol","year":"2008","unstructured":"Krol RP, Nozu K, Nakanishi K et al: Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome. Nephrol Dial Transplant 2008; 23: 2525\u20132530.","journal-title":"Nephrol Dial Transplant"},{"key":"BFejhg2015113_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH : Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31\u201341.","journal-title":"Nephron"},{"key":"BFejhg2015113_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S0022-3476(85)80697-1","volume":"106","author":"GJ Schwartz","year":"1985","unstructured":"Schwartz GJ, Gauthier B : A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985; 106: 522\u2013526.","journal-title":"J Pediatr"},{"key":"BFejhg2015113_CR10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","volume":"58","author":"GJ Schwartz","year":"1976","unstructured":"Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A : A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259\u2013263.","journal-title":"Pediatrics"},{"key":"BFejhg2015113_CR11","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1681\/ASN.V9122291","volume":"9","author":"P Martin","year":"1998","unstructured":"Martin P, Heiskari N, Zhou J et al: High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing. J Am Soc Nephrol 1998; 9: 2291\u20132301.","journal-title":"J Am Soc Nephrol"},{"key":"BFejhg2015113_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nature03001","volume":"431","author":"International Human Genome Sequencing Consortium","year":"2004","unstructured":"International Human Genome Sequencing Consortium: Finishing the euchromatic sequence of the human genome. Nature 2004; 431: 931\u2013945.","journal-title":"Nature"},{"key":"BFejhg2015113_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/humu.9349","volume":"26","author":"M Nagel","year":"2005","unstructured":"Nagel M, Nagorka S, Gross O : Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. Hum Mutat 2005; 26: 60.","journal-title":"Hum Mutat"},{"key":"BFejhg2015113_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/(SICI)1098-1004(1999)13:2<124::AID-HUMU4>3.0.CO;2-Z","volume":"13","author":"KE Plant","year":"1999","unstructured":"Plant KE, Green PM, Vetrie D, Flinter FA : Detection of mutations in COL4A5 in patients with Alport syndrome. Hum Mutat 1999; 13: 124\u2013132.","journal-title":"Hum Mutat"},{"key":"BFejhg2015113_CR15","first-page":"1192","volume":"58","author":"A Renieri","year":"1996","unstructured":"Renieri A, Bruttini M, Galli L et al: X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Am J Hum Genet 1996; 58: 1192\u20131204.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2015113_CR16","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1203\/01.pdr.0000265051.26718.b5","volume":"61","author":"H Kaito","year":"2007","unstructured":"Kaito H, Nozu K, Fu XJ et al: Detection of a transcript abnormality in mRNA of the SLC12A3 gene extracted from urinary sediment cells of a patient with Gitelman's syndrome. Pediatr Res 2007; 61: 502\u2013505.","journal-title":"Pediatr Res"},{"key":"BFejhg2015113_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00439-009-0697-7","volume":"126","author":"K Nozu","year":"2009","unstructured":"Nozu K, Iijima K, Kawai K et al: In vivo and in vitro splicing assay of SLC12A1 in an antenatal salt-losing tubulopathy patient with an intronic mutation. Hum Genet 2009; 126: 533\u2013538.","journal-title":"Hum Genet"},{"key":"BFejhg2015113_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00467-009-1370-z","volume":"25","author":"K Kaneko","year":"2010","unstructured":"Kaneko K, Tanaka S, Hasui M et al: A family with X-linked benign familial hematuria. Pediatr Nephrol 2010; 25: 545\u2013548.","journal-title":"Pediatr Nephrol"},{"key":"BFejhg2015113_CR19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.gene.2013.05.045","volume":"526","author":"S Beicht","year":"2013","unstructured":"Beicht S, Strobl-Wildemann G, Rath S et al: Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome. Gene 2013; 526: 474\u2013477.","journal-title":"Gene"},{"key":"BFejhg2015113_CR20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/jmg.37.9.717","volume":"37","author":"M Bruttini","year":"2000","unstructured":"Bruttini M, Vitelli F, Meloni I et al: Mosaicism in Alport syndrome with genetic counselling. J Med Genet 2000; 37: 717\u2013719.","journal-title":"J Med Genet"},{"key":"BFejhg2015113_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/jmg.37.3.238","volume":"37","author":"KE Plant","year":"2000","unstructured":"Plant KE, Boye E, Green PM, Vetrie D, Flinter FA : Somatic mosaicism associated with a mild Alport syndrome phenotype. J Med Genet 2000; 37: 238\u2013239.","journal-title":"J Med Genet"},{"key":"BFejhg2015113_CR22","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.2215\/CJN.04140414","volume":"9","author":"KVI Nozu","year":"2014","unstructured":"Nozu K VI, Kaito H, Fu XJ et al. X-linked Alport syndrome caused by splicing mutations in COL4A5. Clin J Ame Soc Nephrol 2014; 9: 1958\u20131964.","journal-title":"Clin J Ame Soc Nephrol"},{"key":"BFejhg2015113_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00467-012-2138-4","volume":"28","author":"CE Kashtan","year":"2013","unstructured":"Kashtan CE, Ding J, Gregory M et al: Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. Pediatr Nephrol 2013; 28: 5\u201311.","journal-title":"Pediatr Nephrol"},{"key":"BFejhg2015113_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1681\/ASN.2012020148","volume":"24","author":"J Savige","year":"2013","unstructured":"Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F : Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 2013; 24: 364\u2013375.","journal-title":"J Am Soc Nephrol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2015113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2015113","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2015113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:13:48Z","timestamp":1684430028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2015113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,27]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFejhg2015113"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2015.113","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,27]]},"assertion":[{"value":"8 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KI received grants from Novartis Pharma K.K., Japan Blood Product Organization, Kyowa Hakko Kirion Co., Ltd, JCR Pharmaceuticals Co., Ltd, AbbVie Inc., Genzyme Japan K.K., Teijin Pharma Ltd, Daiichi Sankyo Co., Ltd, and Miyarisan Pharmaceutical Co., Ltd, and lecture fees from Kyowa Hakko Kirin Co., Ltd, Astellas Pharma Inc., Pfizer Japan Inc., Asahi Kasei Pharma Corp., Kowa Pharmaceutical Co., Ltd, Merck Sharp & Dohme Corp., Alexion, Meiji Seika Pharma Co., Ltd, and Novartis Pharma K.K.. KI is also an advisor for Zenyaku Kogyo Co., Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}